Unknown

Dataset Information

0

Metabologenomics: Correlation of Microbial Gene Clusters with Metabolites Drives Discovery of a Nonribosomal Peptide with an Unusual Amino Acid Monomer.


ABSTRACT: For more than half a century the pharmaceutical industry has sifted through natural products produced by microbes, uncovering new scaffolds and fashioning them into a broad range of vital drugs. We sought a strategy to reinvigorate the discovery of natural products with distinctive structures using bacterial genome sequencing combined with metabolomics. By correlating genetic content from 178 actinomycete genomes with mass spectrometry-enabled analyses of their exported metabolomes, we paired new secondary metabolites with their biosynthetic gene clusters. We report the use of this new approach to isolate and characterize tambromycin, a new chlorinated natural product, composed of several nonstandard amino acid monomeric units, including a unique pyrrolidine-containing amino acid we name tambroline. Tambromycin shows antiproliferative activity against cancerous human B- and T-cell lines. The discovery of tambromycin via large-scale correlation of gene clusters with metabolites (a.k.a. metabologenomics) illuminates a path for structure-based discovery of natural products at a sharply increased rate.

SUBMITTER: Goering AW 

PROVIDER: S-EPMC4827660 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Metabologenomics: Correlation of Microbial Gene Clusters with Metabolites Drives Discovery of a Nonribosomal Peptide with an Unusual Amino Acid Monomer.

Goering Anthony W AW   McClure Ryan A RA   Doroghazi James R JR   Albright Jessica C JC   Haverland Nicole A NA   Zhang Yongbo Y   Ju Kou-San KS   Thomson Regan J RJ   Metcalf William W WW   Kelleher Neil L NL  

ACS central science 20160120 2


For more than half a century the pharmaceutical industry has sifted through natural products produced by microbes, uncovering new scaffolds and fashioning them into a broad range of vital drugs. We sought a strategy to reinvigorate the discovery of natural products with distinctive structures using bacterial genome sequencing combined with metabolomics. By correlating genetic content from 178 actinomycete genomes with mass spectrometry-enabled analyses of their exported metabolomes, we paired ne  ...[more]

Similar Datasets

| S-EPMC3897469 | biostudies-literature
2010-07-01 | GSE21373 | GEO
2010-07-30 | E-GEOD-21373 | biostudies-arrayexpress
| S-EPMC5551671 | biostudies-literature
| S-EPMC7163397 | biostudies-literature
| S-EPMC5200924 | biostudies-literature
| S-EPMC5944846 | biostudies-literature
| S-EPMC4851115 | biostudies-literature
| S-EPMC4502231 | biostudies-literature
| S-EPMC9897216 | biostudies-literature